- Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trial2022 | Ústřední knihovna
- Elective surgery cancellations due to the COVID-19 pandemic: global predictive modelling to inform surgical recovery plans2020 | Ústřední knihovna